During the past decade, Division of Metabolic Diseases, University Hospital of Padova conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Division of Metabolic Diseases, University Hospital of Padova" #1 collaborator was "Azienda Ospedaliera di Padova" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Division of Metabolic Diseases, University Hospital of Padova" are "Phenylketonuria" (2 trials), "Type 2 Diabetes" (2 trials) and "Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Division of Metabolic Diseases, University Hospital of Padova" in a lesser frequency.

Most popular intervention types in "Division of Metabolic Diseases, University Hospital of Padova" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "PTC923" (2 trials), "Placebo" (2 trials), "Dapagliflozin" (1 trials), "GLP-1 receptor agonist" (1 trials) and "Insulin degludec" (1 trials). Other intervention names were less common.

The vast majority of trials in "Division of Metabolic Diseases, University Hospital of Padova" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Division of Metabolic Diseases, University Hospital of Padova". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Division of Metabolic Diseases, University Hospital of Padova, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Division of Metabolic Diseases, University Hospital of Padova, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".